Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Bluetooth-based contact-tracing apps could enhance vaccine strategies

Mathematical modeling of disease spread suggests that herd immunity could be achieved with fewer vaccine doses by using Bluetooth-based contact-tracing apps to identify people who have more exposure to others-;and targeting them for vaccination.

22 Sep 2021

Ryans make $25 million gift to name and endow the Robert J. Havey, MD, Institute for Global Health

Northwestern University Trustees and alumni Patrick G. Ryan and Shirley W. Ryan have made a $25 million gift to name and endow the Robert J. Havey, MD, Institute for Global Health at Northwestern University Feinberg School of Medicine.

22 Sep 2021

COVID-19 may have had a greater impact on mental health of aging women with trauma histories

Beyond the physical dangers of COVID-19, the pandemic has wreaked havoc mentally and emotionally. A new study suggests the pandemic may have had a greater impact on the mental health of women with a history of childhood abuse or intimate partner violence (IPV) than with women without such histories.

22 Sep 2021

COVID-19 will become a seasonal disease, U-M epidemiologist says

A University of Michigan epidemiologist believes that COVID-19 will become a seasonal disease, likely in the fall and winter seasons.

22 Sep 2021

First UK-manufactured lateral flow devices rolled out to universities across England

The first UK-manufactured rapid tests - otherwise known as lateral flow devices or LFDs - are being rolled out to universities across England.

22 Sep 2021

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

Scientists from the USA have recently compared the dynamics of humoral and cellular immune responses induced by mRNA-based and adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccines. The findings reveal a difference in humoral immune responses. The study is currently available on the medRxiv* preprint server.

22 Sep 2021

The importance of handwashing in the COVID-19 era: Back to basics

Researchers from the United States have reviewed the different components of formulated soaps and their performance as cleansers and pathogen inactivators, the criticality of the time spent hand washing, the relationships between water temperature and pathogen inactivation.

22 Sep 2021

The role of nanomaterials during the COVID-19 pandemic

A new review published in Rare Metals has focused on the applications of nanomaterials to fight the ongoing COVID-19 pandemic.

22 Sep 2021

Will ‘Dr. Disinformation’ ever face the music?

Earlier this month, Dr. Rashid Buttar posted on Twitter that covid-19 "was a planned operation" and shared an article alleging that most people who got the covid vaccine would be dead by 2025.

22 Sep 2021

Hypertonic saline solution shown to inhibit replication of SARS-CoV-2

Researchers at the University of São Paulo (USP) in Brazil have shown that a hypertonic saline solution inhibits replication of SARS-CoV-2, the virus that causes COVID-19, and have elucidated the biochemical mechanism involved.

22 Sep 2021

Unique tiny Ilamas antibodies could be used for treatment of COVID-19

A unique type of tiny antibody produced by llamas could provide a new frontline treatment against Covid-19 that can be taken by patients as a simple nasal spray.

22 Sep 2021

SARS-CoV-2 genome signature leads to replicative advantage in presence of Remdesivir

A new study indicates that low-level resistance of SARS-CoV-2 to remdesivir is not widespread and dissimilar to other RNA viruses revealing evolutionary predictability of this pandemic virus.

22 Sep 2021

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

President Joe Biden's failure to name someone to lead the Food and Drug Administration, more than 10 months after the election, has flummoxed public health experts who say it's baffling for the agency to be without a permanent leader during a national health crisis.

22 Sep 2021

At an overrun ICU, ‘the problem is we are running out of hallways’

Nurses fill the hospital room to turn a patient from his stomach to his back. The ventilator forcing air into him is most effective when he's on his stomach, so he is in that position most hours of the day, sedated and paralyzed by drugs.

22 Sep 2021

SARS-CoV-2 delta variant has higher viral RNA levels and increased infectivity, suggests study

The study found that the delta and epsilon variants exhibited significantly higher infectivity than alpha, with delta containing approximately six times as much infectious virus for the same amount of RNA.

22 Sep 2021

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

PerkinElmer today announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents.

From Revvity 22 Sep 2021

Experts discover new approach to motivate people for vaccinations and masking

In the face of a global pandemic, with more than 200 million global infections and 4 million deaths, and despite unprecedented efforts by public health officials, celebrities and influencers to convince everyone to wear masks and get vaccinated as soon possible, the results are mixed.

22 Sep 2021

New cohort of startup companies chosen for first-of-its-kind BlueSwell incubator program

SeaAhead, Inc. and the New England Aquarium have chosen a new cohort of startup companies for BlueSwell, a first-of-its-kind incubator program in the Northeast focused on supporting early-stage entrepreneurship in Bluetech.

22 Sep 2021

New framework needed to explore links between evolved pathogen tolerance and emerging infections

A new multidisciplinary research framework is needed to explore links between evolved tolerance to pathogens and their spillover into humans, scientists write today in the journal eLife.

22 Sep 2021

Cardiothoracic surgeons implant novel type of artificial heart in a female patient

A cardiothoracic surgical team with UofL Health – Jewish Hospital and the University of Louisville has performed the world's first Aeson® bioprosthetic total artificial heart implantation in a female patient. The investigational device, currently intended as a bridge to heart transplant, is part of an Early Feasibility Study (EFS) sponsored by CARMAT, a French medical device company, in partnership with UofL, UofL Health – Jewish Hospital and the UofL Health – Trager Transplant Center.

22 Sep 2021

Pandemic News and Research

Further Reading

Bluetooth-based contact-tracing apps could enhance vaccine strategies

Ryans make $25 million gift to name and endow the Robert J. Havey, MD, Institute for Global Health

COVID-19 may have had a greater impact on mental health of aging women with trauma histories

COVID-19 will become a seasonal disease, U-M epidemiologist says

First UK-manufactured lateral flow devices rolled out to universities across England

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

The importance of handwashing in the COVID-19 era: Back to basics

The role of nanomaterials during the COVID-19 pandemic

Will ‘Dr. Disinformation’ ever face the music?

Hypertonic saline solution shown to inhibit replication of SARS-CoV-2

Unique tiny Ilamas antibodies could be used for treatment of COVID-19

SARS-CoV-2 genome signature leads to replicative advantage in presence of Remdesivir

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

At an overrun ICU, ‘the problem is we are running out of hallways’

SARS-CoV-2 delta variant has higher viral RNA levels and increased infectivity, suggests study

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

Experts discover new approach to motivate people for vaccinations and masking

New cohort of startup companies chosen for first-of-its-kind BlueSwell incubator program

New framework needed to explore links between evolved pathogen tolerance and emerging infections

Cardiothoracic surgeons implant novel type of artificial heart in a female patient

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News